Medical Condition Requiring Extracorporeal Organ SupportNCT05811780
The University of Freiburg Medical Center Extracorporeal Organ Support Device Registry
An observational study of Medical Condition Requiring Extracorporeal Organ Support, run by University Hospital Freiburg at 1 site in Germany.
Trial summary
A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Medical Condition Requiring Extracorporeal Organ Support
- How many people
- 1,500 participants
- Where
- 1 siteGermany
- Study dates
- 29 Apr 2014to 31 Dec 2035
- How long will I take part?
- 10 Years
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All patients receiving extracorporeal organ support and being treated in the Department of Interdisciplinary Medical Intensive Care of the Freiburg University Medical Center
Who may be able to join
- Treatment with any kind of extracorporeal organ support
Who cannot join
- none
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Germany1 site, 1 recruiting
- Recruiting
University of Freiburg Medical Center
Freiburg im Breisgau, 79106
Tobias Wengenmayer, Prof. Dr., +49761270 ext. 35910, tobias.wengenmayer@uniklinik-freiburg.de
About this study
A prospective registry collecting pseudonymized clinical and treatment data from all patients treated with extracorporeal organ support (i.e., VV ECMO, VA ECMO, ECPR, Impella, IABP, and others) on the wards of the Department of Interdisciplinary Medical Intensive Care at the Freiburg University Medical Center.
- Keywords
- Acute Respiratory Distress Syndrome, acute respiratory failure, severe respiratory failure, cardiogenic shock, cardiac arrest, extracorporeal cardiopulmonary resuscitation
- Medical subject headings
- Respiratory Distress Syndrome, Respiratory Insufficiency, Shock, Cardiogenic, Heart Arrest
What is being measured
The primary outcome is the main question the study is designed to answer.
Hospital survival
Survival of index hospitalization (yes/no)
Measured: 30 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2023
- Study start29 Apr 2014
- Primary completion31 Dec 2030 (estimated)
- Study completion31 Dec 2035 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medical Condition Requiring Extracorporeal Organ SupportStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 1,500 participants (estimated)
- Target duration
- 10 Years
Sponsor and investigators
- Lead sponsor
- University Hospital Freiburg
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, PD Dr. Alexander Supady, University Hospital Freiburg
- Investigators
- Tobias Wengenmayer, Prof. Dr., Study director, University of FreiburgDawid L Staudacher, PD Dr., Principal investigator, University of FreiburgPaul M Biever, Dr., Principal investigator, University of FreiburgJonathan Rilinger, PD Dr., Principal investigator, University of FreiburgAlexander Supady, PD Dr., Principal investigator, University of Freiburg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05811780
- Sponsor's protocol ID
- 151/14
- Status last verified
- Mar 2023
- First submitted
- 20 Mar 2023
- Last updated
- 13 Apr 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No